Signaling pathways
-
BA4597 BMS-688521Summary: BMS-688521 is a potent, orally active interaction inhibitor. - BA4598 ValategrastSummary: Valategrast (R-411freebase) is a potent orally active integrin and dual antagonist.
- BA4599 LDVSummary: LDV is a non-fluorescent analog of LDV-FITC.
- BA4600 ZalunfibanSummary: Zalunfiban (RUC-4) is a potent and selective platelet antagonist (=45nM).
- BA4601 RGD-4CSummary: RGD-4C is an arginine-glycine-aspartate peptide with integrin binding activity (ACDCRGDCFC).
- BA4602 SibrafibanSummary: Sibrafiban (RO48-3657) is an Ro44-3888 orally active, non-peptide, dual precursor that is a selective glycoprotein IIb/IIIa receptor antagonist.
- BA4603 FITC-Ahx-Gly-Arg-Gly-Asp-Ser-ProSummary: FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro is coupled to FITC.
- BA4604 GRGDSPKSummary: GRGDSPK (EMD56574) is a polypeptide containing arginine-glycine-aspartic acid (RGD).
- BA4606 FuzapladibSummary: Fuzapladib (IS-741) is an orally active inhibitor of leukocyte function-related antigen type 1 activation, a leukocyte adhesion molecule.
- BA4607 K34cSummary: K34c is a potent and selective antagonist.